Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adalimumab for treatment of juvenile ankylosing spondylitis: randomized double-blind placebo-controlled phase III trial
2007-003358-27Phase 3Completed
- Sponsor
- Asklepios Klinik Sankt Augustin
- Start
- Nov 2007
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in ankylosing spondylitis (AS) comparing Adalimumab arm with Placebo arm (2 arms). Primary endpoint: ASAS40 response at Week 12. Started Nov 2007; status: completed.
02
Drugs
03
Conditions
ankylosing spondylitis (AS)
Beyond the preview
Go deeper on 2007-003358-27.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-003358-27.